Soluble urokinase plasminogen activator receptor is associated with cardiovascular calcification in peritoneal dialysis patients.

Guan, Jichao; Gong, Shuwen; He, Qiuli; Wang, Xiaoling; Shen, Shuijuan; Wu, Xiujuan; Shan, Juanping; Gong, Tujian; Yang, Yanru; Xie, Haiying

Guan, Jichao; Gong, Shuwen; He, Qiuli; Wang, Xiaoling; Shen, Shuijuan; Wu, Xiujuan; Shan, Juanping; Gong, Tujian; Yang, Yanru; Xie, Haiying.

Affiliation

Guan J; Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
Gong S; Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
He Q; Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
Wang X; Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
Shen S; Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
Wu X; Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
Shan J; Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
Gong T; Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
Yang Y; Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
Xie H; Shaoxing People's Hospital, Shaoxing, Zhejiang, China. xiaoxia399@aliyun.com.

Int Urol Nephrol ; 56(1): 191-198, 2024 Jan.

Article de En | MEDLINE | ID: mdl-37195572

Sujet(s)
Mots clés

Cardiovascular calcification; Cardiovascular disease; Peritoneal dialysis; Soluble urokinase plasminogen activator receptor

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie des artères coronaires / Calcinose / Maladies cardiovasculaires / Dialyse péritonéale Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Int Urol Nephrol Année: 2024 Type de document: Article Pays d'affiliation: Chine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google